Annual CFF
-$5.50 M
-$3.31 M-150.34%
31 December 2023
Summary:
Organogenesis Holdings annual cash flow from financing activities is currently -$5.50 million, with the most recent change of -$3.31 million (-150.34%) on 31 December 2023. During the last 3 years, it has fallen by -$47.97 million (-112.96%). ORGO annual CFF is now -106.75% below its all-time high of $81.54 million, reached on 31 December 2018.ORGO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CFF
-$1.68 M
+$50.00 K+2.90%
30 September 2024
Summary:
Organogenesis Holdings quarterly cash flow from financing activities is currently -$1.68 million, with the most recent change of +$50.00 thousand (+2.90%) on 30 September 2024. Over the past year, it has dropped by -$239.00 thousand (-16.62%). ORGO quarterly CFF is now -103.46% below its all-time high of $48.51 million, reached on 30 September 2018.ORGO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CFF
-$7.79 M
-$239.00 K-3.17%
30 September 2024
Summary:
Organogenesis Holdings TTM cash flow from financing activities is currently -$7.79 million, with the most recent change of -$239.00 thousand (-3.17%) on 30 September 2024. Over the past year, it has dropped by -$2.19 million (-39.01%). ORGO TTM CFF is now -107.98% below its all-time high of $97.59 million, reached on 31 March 2019.ORGO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ORGO Cash From Financing Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -150.3% | -16.6% | -39.0% |
| 3 y3 years | -113.0% | -232.1% | -126.0% |
| 5 y5 years | -106.8% | -117.2% | -117.3% |
ORGO Cash From Financing High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | -113.0% | at low | -232.1% | +35.7% | -126.0% | at low |
| 5 y | 5 years | -106.8% | at low | -103.6% | +35.7% | -109.9% | at low |
| alltime | all time | -106.8% | at low | -103.5% | +35.7% | -108.0% | at low |
Organogenesis Holdings Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$1.68 M(-2.9%) | -$7.79 M(+3.2%) |
| June 2024 | - | -$1.73 M(-33.8%) | -$7.55 M(+9.8%) |
| Mar 2024 | - | -$2.61 M(+46.8%) | -$6.88 M(+24.9%) |
| Dec 2023 | -$5.50 M(+150.3%) | -$1.78 M(+23.6%) | -$5.50 M(-1.7%) |
| Sept 2023 | - | -$1.44 M(+36.4%) | -$5.60 M(+35.4%) |
| June 2023 | - | -$1.05 M(-14.7%) | -$4.14 M(+55.0%) |
| Mar 2023 | - | -$1.24 M(-34.1%) | -$2.67 M(+21.4%) |
| Dec 2022 | -$2.20 M(+112.3%) | -$1.88 M(-7311.5%) | -$2.20 M(+77.2%) |
| Sept 2022 | - | $26.00 K(-93.7%) | -$1.24 M(<-9900.0%) |
| June 2022 | - | $415.00 K(-154.2%) | $3000.00(-100.2%) |
| Mar 2022 | - | -$765.00 K(-16.6%) | -$1.21 M(+16.8%) |
| Dec 2021 | -$1.04 M(-102.4%) | -$917.00 K(-172.2%) | -$1.04 M(-103.5%) |
| Sept 2021 | - | $1.27 M(-259.1%) | $30.00 M(+7.3%) |
| June 2021 | - | -$798.00 K(+35.0%) | $27.96 M(-16.9%) |
| Mar 2021 | - | -$591.00 K(-102.0%) | $33.65 M(-20.8%) |
| Dec 2020 | $42.47 M | $30.12 M(-3986.8%) | $42.47 M(-28.5%) |
| Sept 2020 | - | -$775.00 K(-115.8%) | $59.41 M(-15.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | $4.89 M(-40.6%) | $69.92 M(+3.1%) |
| Mar 2020 | - | $8.23 M(-82.5%) | $67.82 M(-13.8%) |
| Dec 2019 | $78.73 M(-3.4%) | $47.07 M(+383.9%) | $78.73 M(+75.2%) |
| Sept 2019 | - | $9.73 M(+247.9%) | $44.94 M(-46.3%) |
| June 2019 | - | $2.80 M(-85.4%) | $83.72 M(-14.2%) |
| Mar 2019 | - | $19.13 M(+44.0%) | $97.59 M(+19.7%) |
| Dec 2018 | $81.54 M(+332.2%) | $13.29 M(-72.6%) | $81.54 M(-6.9%) |
| Sept 2018 | - | $48.51 M(+191.1%) | $87.55 M(+124.2%) |
| June 2018 | - | $16.66 M(+440.7%) | $39.04 M(+74.5%) |
| Mar 2018 | - | $3.08 M(-84.0%) | $22.38 M(+18.6%) |
| Dec 2017 | $18.87 M(+178.4%) | $19.29 M(>+9900.0%) | $18.87 M(+200.5%) |
| Sept 2017 | - | $0.00(0.0%) | $6.28 M(-1.4%) |
| June 2017 | - | $0.00(-100.0%) | $6.37 M(0.0%) |
| Mar 2017 | - | -$427.60 K(-106.4%) | $6.37 M(-6.0%) |
| Dec 2016 | $6.78 M | $6.71 M(+7326.0%) | $6.78 M(+9538.7%) |
| Sept 2016 | - | $90.30 K(>+9900.0%) | $70.30 K(-451.5%) |
| June 2016 | - | $0.00(-100.0%) | -$20.00 K(0.0%) |
| Mar 2016 | - | -$20.00 K | -$20.00 K |
FAQ
- What is Organogenesis Holdings annual cash flow from financing activities?
- What is the all time high annual CFF for Organogenesis Holdings?
- What is Organogenesis Holdings annual CFF year-on-year change?
- What is Organogenesis Holdings quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Organogenesis Holdings?
- What is Organogenesis Holdings quarterly CFF year-on-year change?
- What is Organogenesis Holdings TTM cash flow from financing activities?
- What is the all time high TTM CFF for Organogenesis Holdings?
- What is Organogenesis Holdings TTM CFF year-on-year change?
What is Organogenesis Holdings annual cash flow from financing activities?
The current annual CFF of ORGO is -$5.50 M
What is the all time high annual CFF for Organogenesis Holdings?
Organogenesis Holdings all-time high annual cash flow from financing activities is $81.54 M
What is Organogenesis Holdings annual CFF year-on-year change?
Over the past year, ORGO annual cash flow from financing activities has changed by -$3.31 M (-150.34%)
What is Organogenesis Holdings quarterly cash flow from financing activities?
The current quarterly CFF of ORGO is -$1.68 M
What is the all time high quarterly CFF for Organogenesis Holdings?
Organogenesis Holdings all-time high quarterly cash flow from financing activities is $48.51 M
What is Organogenesis Holdings quarterly CFF year-on-year change?
Over the past year, ORGO quarterly cash flow from financing activities has changed by -$239.00 K (-16.62%)
What is Organogenesis Holdings TTM cash flow from financing activities?
The current TTM CFF of ORGO is -$7.79 M
What is the all time high TTM CFF for Organogenesis Holdings?
Organogenesis Holdings all-time high TTM cash flow from financing activities is $97.59 M
What is Organogenesis Holdings TTM CFF year-on-year change?
Over the past year, ORGO TTM cash flow from financing activities has changed by -$2.19 M (-39.01%)